Illumina's Q2 Revenues Rise 36 Percent

The firm's consumables revenues increased 26 percent to $159 million, while its instrument revenues increased 53 percent to $107 million, driven by shipments of its HiSeq, HiScan, and HiScanSQ systems.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories